Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia

Placental Protein 13 as an Early Predictor in Egyptian Patients With Preeclampsia, Correlation to Risk, and Association With Outcome

(2016) Walid S. El Sherbiny et al.   JOURNAL OF INVESTIGATIVE MEDICINE

Associations of Pregnancy Complications With Calculated Cardiovascular Disease Risk and Cardiovascular Risk Factors in Middle Age

(2012) Abigail Fraser et al.   CIRCULATION

Epigenetics and microRNAs in Preeclampsia

(2012) Mahua Choudhury et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

Combined Screening for Preeclampsia and Small for Gestational Age at 11–13 Weeks

(2012) Leona C.Y. Poon et al.   FETAL DIAGNOSIS AND THERAPY

First-Trimester Prediction of Preeclampsia in Nulliparous Women at Low Risk

(2012) Leslie Myatt et al.   OBSTETRICS AND GYNECOLOGY

First trimester screening of maternal placental protein 13 for predicting preeclampsia and small for gestational age: In-house study and systematic review

(2012) F.J. Schneuer et al.   PLACENTA

First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia

(2012) G. Di Lorenzo et al.   PLACENTA

Placental protein 13 (PP13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome

(2011) Andrea Balogh et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Evaluation and management of severe preeclampsia before 34 weeks' gestation

(2011) Baha M. Sibai   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

(2011) Ravi Thadhani et al.   CIRCULATION

Evaluation of 7 Serum Biomarkers and Uterine Artery Doppler Ultrasound for First-Trimester Prediction of Preeclampsia: A Systematic Review

(2011) Sylwia Kuc et al.   OBSTETRICAL & GYNECOLOGICAL SURVEY

Placenta-bound and Body Fluid PP13 and its mRNA in Normal Pregnancy Compared to Preeclampsia, HELLP and Preterm Delivery

(2011) M. Sammar et al.   PLACENTA

The secretion of PAPP-A, ADAM12, and PP13 correlates with the size of the placenta for the first month of pregnancy

(2011) M. Sahraravand et al.   PLACENTA

First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia

(2011) A.O. Odibo et al.   PLACENTA

Placental and trophoblastic in vitro models to study preventive and therapeutic agents for preeclampsia

(2011) K. Orendi et al.   PLACENTA

Screening for Pre-eclampsia–Lessons from Aneuploidy Screening

(2011) H.S. Cuckle   PLACENTA

PP13 as a marker of pre-eclampsia: A two platform comparison study

(2011) N.J. Cowans et al.   PLACENTA

PP13, Maternal ABO Blood Groups and the Risk Assessment of Pregnancy Complications

(2011) Nandor Gabor Than et al.   PLoS One

Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks

(2011) Ranjit Akolekar et al.   PRENATAL DIAGNOSIS

Placental Protein 13 and Decidual Zones of Necrosis: An Immunologic Diversion That May be Linked to Preeclampsia

(2011) Harvey J. Kliman et al.   Reproductive Sciences

Galectins: guardians of eutherian pregnancy at the maternal–fetal interface

(2011) Nandor Gabor Than et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women

(2010) François Audibert et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks

(2010) Antonio Farina et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia

(2010) EJ Wortelboer et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy

(2010) Emmanuel Bujold et al.   OBSTETRICS AND GYNECOLOGY

Effects of vitamins C and E, acetylsalicylic acid and heparin on fusion, beta-hCG and PP13 expression in BeWo cells

(2010) K. Orendi et al.   PLACENTA

Effects of calcium, magnesium, low-dose aspirin and low-molecular-weight heparin on the release of PP13 from placental explants

(2010) Y.-I. Grimpel et al.   PLACENTA

ASH Position Paper: Hypertension in Pregnancy

(2009) Marshall D. Lindheimer et al.   Journal of Clinical Hypertension

Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension?

(2009) S K Srinivas et al.   Journal of Perinatology

A novel exonic variant (221delT) in the LGALS13 gene encoding placental protein 13 (PP13) is associated with preterm labour in a low risk population

(2009) S. Gebhardt et al.   JOURNAL OF REPRODUCTIVE IMMUNOLOGY

PP13 mRNA expression in the cellular component of maternal blood as a marker for preeclampsia

(2009) Hanako Shimizu et al.   PRENATAL DIAGNOSIS

First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women witha priorihigh risk

(2009) Asma Khalil et al.   PRENATAL DIAGNOSIS

Maternal serum placental protein 13 at 11–13 weeks of gestation in preeclampsia

(2009) Ranjit Akolekar et al.   PRENATAL DIAGNOSIS

A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death

(2009) N. G. Than et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

First-trimester maternal serum PP13 in the risk assessment for preeclampsia

(2008) Roberto Romero et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study

(2008) R Gonen et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Severe maternal morbidity during pregnancy, delivery and puerperium in the Netherlands: a nationwide population-based study of 371 000 pregnancies

(2008) JJ Zwart et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Longitudinal Determination of Serum Placental Protein 13 during Development of Preeclampsia

(2008) Berthold Huppertz et al.   FETAL DIAGNOSIS AND THERAPY

Placental Origins of Preeclampsia

(2008) Berthold Huppertz   HYPERTENSION

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate

(2008) Roberto Romero et al.   Journal of Maternal-Fetal & Neonatal Medicine

PP13 mRNA Expression in Trophoblasts From Preeclamptic Placentas

(2008) Akihiko Sekizawa et al.   Reproductive Sciences

Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome

(2008) Nandor Gabor Than et al.   VIRCHOWS ARCHIV